Ghaziabad Online

Phenylketonuria Market to Witness Growth by (2022-2032), Estimates DelveInsight | Key Companies – PTC Therapeutics, BioMarin Pharmaceuticals, Homology Medicines and Synlogic

 Breaking News
  • No posts were found

Phenylketonuria Market to Witness Growth by (2022-2032), Estimates DelveInsight | Key Companies – PTC Therapeutics, BioMarin Pharmaceuticals, Homology Medicines and Synlogic

November 09
19:01 2022
Phenylketonuria Market to Witness Growth by (2022-2032), Estimates DelveInsight | Key Companies - PTC Therapeutics, BioMarin Pharmaceuticals, Homology Medicines and Synlogic
The Phenylketonuria market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Phenylketonuria pipeline products will significantly revolutionize the Phenylketonuria market dynamics.

DelveInsight’s “Phenylketonuria Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Phenylketonuria, historical and forecasted epidemiology as well as the Phenylketonuria market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Phenylketonuria market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

 

To Know in detail about the Phenylketonuria market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Phenylketonuria Market Insights

 

Phenylketonuria Overview

Phenylketonuria (PKU) is an inborn error of metabolism that is detectable during the first days of life via routine newborn screening. PKU is characterized by the absence or deficiency of an enzyme called phenylalanine hydroxylase (PAH), responsible for processing the amino acid phenylalanine. Amino acids are the chemical building blocks of proteins and are essential for proper growth and development. With normal PAH activity, phenylalanine is converted to another amino acid, tyrosine. 

However, when PAH is absent or deficient, phenylalanine accumulates and is toxic to the brain. Without treatment, most people with PKU would develop a severe intellectual disability. To prevent intellectual disability, treatment consists of a carefully controlled, phenylalanine-restricted diet beginning during the first days or weeks of life.

 

Some of the key facts of the Phenylketonuria Market Report: 

  • The Phenylketonuria market size was valued at USD 630 Million in the year 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032) 
  • Total Diagnosed Prevalent Cases of Phenylketonuria (PKU) in the 7MM was found to be 49,601 cases in 2021 
  • Among 7MM, the United States has highest number of Phenylketonuria diagnosed cases with 17, 533 cases in 2021 
  • In the United States, the highest number of cases of Phenylketonuria were found in the age group and the lowest number of cases were found in the age group of 45 years and above 
  • Key Phenylketonuria Companies: PTC Therapeutics, BioMarin Pharmaceuticals, Homology Medicines and Synlogic, and others
  • Key Phenylketonuria Therapies: CNSA-001, HMI-102, SYNB1618, BMN-3017, and others

 

Get a Free sample for the Phenylketonuria Market Report

https://www.delveinsight.com/sample-request/phenylketonuria-pku-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr

 

Key benefits of the Phenylketonuria Market report:

  1. Phenylketonuria market report covers a descriptive overview and comprehensive insight of the Phenylketonuria Epidemiology and Phenylketonuria market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Phenylketonuria market report provides insights on the current and emerging therapies.
  3. Phenylketonuria market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Phenylketonuria market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Phenylketonuria market.

 

Download the report to understand which factors are driving Phenylketonuria epidemiology trends @ Phenylketonuria Epidemiological Insights 

 

Phenylketonuria Market  

The dynamics of the Phenylketonuria market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032. 

 

Phenylketonuria Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

 

Phenylketonuria Epidemiology Segmentation:

The Phenylketonuria market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Phenylketonuria
  • Prevalent Cases of Phenylketonuria by severity
  • Gender-specific Prevalence of Phenylketonuria
  • Diagnosed Cases of Episodic and Chronic Phenylketonuria

 

Phenylketonuria Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Phenylketonuria market or expected to get launched during the study period. The analysis covers Phenylketonuria market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Phenylketonuria Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

 

Discover more about therapies set to grab major Phenylketonuria market share @ Phenylketonuria market forecast 

 

Phenylketonuria Therapies and Key Companies

  • CNSA-001: PTC Therapeutics
  • HMI-102: Homology Medicines
  • SYNB1618: Synlogic
  • BMN-3017: BioMarin Pharmaceuticals

 

Phenylketonuria Market Drivers

  • The introduction of novel products
  • Increasing prevalence
  • Awareness about the disease
  • Research and development strategies
  • Widespread newborn screening program

 

Scope of the Phenylketonuria Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Phenylketonuria Companies: PTC Therapeutics, Homology Medicines, Synlogic, BioMarin Pharmaceuticals, and others
  • Key Phenylketonuria Therapies: CNSA-001, HMI-102, SYNB1618, BMN-3017, and others
  • Phenylketonuria Therapeutic Assessment: Phenylketonuria current marketed and Phenylketonuria emerging therapies
  • Phenylketonuria Market Dynamics:  Phenylketonuria market drivers and Phenylketonuria market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Phenylketonuria Unmet Needs, KOL’s views, Analyst’s views, Phenylketonuria Market Access and Reimbursement 

 

Phenylketonuria Market Barriers

  • Unclear comorbidities
  • Limitations associated with the current treatment

 

Table of Contents 

1. Phenylketonuria Market Report Introduction

2. Executive Summary for Phenylketonuria

3. SWOT analysis of Phenylketonuria

4. Phenylketonuria Patient Share (%) Overview at a Glance

5. Phenylketonuria Market Overview at a Glance

6. Phenylketonuria Disease Background and Overview

7. Phenylketonuria Epidemiology and Patient Population

8. Country-Specific Patient Population of Phenylketonuria 

9. Phenylketonuria Current Treatment and Medical Practices

10. Phenylketonuria Unmet Needs

11. Phenylketonuria Emerging Therapies

12. Phenylketonuria Market Outlook

13. Country-Wise Phenylketonuria Market Analysis (2019–2032)

14. Phenylketonuria Market Access and Reimbursement of Therapies

15. Phenylketonuria Market Drivers

16. Phenylketonuria Market Barriers

17.  Phenylketonuria Appendix

18. Phenylketonuria Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

To know more about Phenylketonuria treatment, visit @ Phenylketonuria Medications  

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com